S. 113 · 118th Congress (2023–2025)
Prescription Pricing for the People Act of 2023
Prescription Pricing for the People Act of 2023
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Show official title
A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReported by committee
This bill’s path
This is S. 113’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Chuck Grassley (R-IA)
- Cosponsors
21 cosponsors
8 original · 13 later
10 R · 10 D · 1 I
- Sen. Marsha Blackburn (R-TN)· Original · Jan 26, 2023
- Sen. Richard Blumenthal (D-CT)· Original · Jan 26, 2023
- Sen. Mike Braun (R-IN)· Original · Jan 26, 2023
- Sen. Maria Cantwell (D-WA)· Original · Jan 26, 2023
- Sen. Shelley Moore Capito (R-WV)· Original · Jan 26, 2023
- Sen. James Lankford (R-OK)· Original · Jan 26, 2023
- Sen. Tommy Tuberville (R-AL)· Original · Jan 26, 2023
- Sen. Thom Tillis (R-NC)· Original · Jan 26, 2023
- Sen. John Boozman (R-AR)· Later · Jan 30, 2023
- Sen. Christopher A. Coons (D-DE)· Later · Feb 7, 2023
- Sen. Peter Welch (D-VT)· Later · Feb 7, 2023
- Sen. Dianne Feinstein (D-CA)· Later · Feb 9, 2023
- Sen. Mazie K. Hirono (D-HI)· Later · Feb 9, 2023
- Sen. Robert P. Casey Jr. (D-PA)· Later · Mar 16, 2023
- Sen. Kyrsten Sinema (I-AZ)· Later · Mar 21, 2023
- Sen. Roger Marshall (R-KS)· Later · Mar 29, 2023
- Sen. Ted Budd (R-NC)· Later · Apr 19, 2023
- Sen. Jacky Rosen (D-NV)· Later · Sep 27, 2023
- Sen. Susan M. Collins (R-ME)· Later · Nov 9, 2023
- Sen. Jeanne Shaheen (D-NH)· Later · Nov 9, 2023
- Sen. Raphael G. Warnock (D-GA)· Later · Jul 10, 2024
- Policy area
- Commerce
- Subjects
- Business ethics
- Business records
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Health care costs and insurance
- Health information and medical records
- Inflation and prices
2 more
- Prescription drugs
- Retail and wholesale trades
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
▸ 3 committee actions · Jan 26, 2023 – Mar 1, 2023
Referred to committee
Read twice and referred to the Committee on the Judiciary.
Sources
- Congress.gov action
- Senate
Ordered reported
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Sources
- Congress.gov action
- Senate
Reported by committee
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Reported by committee → No further action before the 118th Congress ended.
Committees
Feb 9, 2023 · Meeting
Feb 2, 2023 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
Titles (2)
Prescription Pricing for the People Act of 2023
Display title, Short title · Introduced in Senate, Reported to Senate
A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Official title · Introduced in Senate